36. Kết quả phẫu thuật triệt căn điều trị ung thư biểu mô dạ dày ở người cao tuổi: Hồi cứu 90 ca bệnh

Abstract

Gastric adenocarcinoma is a common disease. In 80% of cases, gastric cancers are detected after the age of 65. We conducted a retrospective study including patients over 60 years old treated for gastric cancer at Vietduc University Hospital from January 2019 to December 2022. The aim of this study was to evaluate the short-term safety and long-term benefits of radical gastrectomy for gastric cancer in elderly patients. Nighty patients were included. The mean age was 68.3 years (60 - 93). The male/female ratio was 2.7. The tumor was revealed by epigastralgia, deterioration of performance status, vomiting, and digestive hemorrhages at 85.5%, 40%, 20%, and 11%, respectively. Endoscopy showed that tumors occurred in the lower third, middle third, and upper third at 68.9%, 26.7%, and 4.4%, respectively. According to the TNM, stages I, II, and III were 42.1%, 17.8%, and 40.1%, respectively. Co-morbidities were cardiovascular disease (40% hypertension, 37.8% heart valves), diabetes mellitus (37.8%), and respiratory disease (41.1%). Distal and total gastrectomy were 93.4% and 6.6%. D2 and D2+ lymph nodes radical were 73.3% and 26.7%. Morbidity and mortality were 11.1% and 0%. The mean of hospital stay was 9.6 days (6 - 20), and overall survival was 30.7 months (12 - 43). The overall survival after 1-, 2-, and 3-years was 86.7%, 71.1%, and 63.3%, respectively. In conclusion, radical gastrectomy is feasible and effective for elderly patients. However, radical surgery selection would depend on the patients‘ general condition and co-morbidities.